# Determination of the Prevalence of Unrecognized Heart Failure Among Patients at Risk in Urban Areas Across Germany Using CMR

> **NCT07185100** · — · RECRUITING · sponsor: **German Heart Institute** · enrollment: 600 (estimated)

## Conditions studied

- Heart Failure With Preserved Ejection Fraction (HFPEF)
- Renal Dysfunction
- Stage B Heart Failure

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT07185100
- **Lead sponsor:** German Heart Institute
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2025-09-13
- **Primary completion:** 2026-12-31
- **Final completion:** 2036-12-31
- **Target enrollment:** 600 (ESTIMATED)
- **Last updated:** 2026-04-01

## Collaborators

- AstraZeneca
- Philips Healthcare
- Deutsches Herzzentrum der Charité, Berlin
- German Heart Center Foundation
- Nationale Herzallianz (NHA)
- Deutsche Herzstiftung

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07185100

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07185100, "Determination of the Prevalence of Unrecognized Heart Failure Among Patients at Risk in Urban Areas Across Germany Using CMR". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT07185100. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*